(Q30448720)

21 June 2017

1 reference

title

Advances in the treatment of menopausal symptoms (English)

1 reference

21 June 2017

1

JoAnn V Pinkerton

1 reference

21 June 2017

Dale W Stovall

2

1 reference

21 June 2017

Rebecca S Kightlinger

series ordinal

3

1 reference

21 June 2017

publication date

1 July 2009

1 reference

21 June 2017

1 reference

21 June 2017

volume

5

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

361-384; quiz 383-4

1 reference

Hot flashes: epidemiology and physiology

21 June 2017

cites work

1 reference

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups

21 January 2018

1 reference

Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation

21 January 2018

1 reference

Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial

21 January 2018

1 reference

Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age.

21 January 2018

1 reference

Physical Activity Alone and in Combination With Hormone Replacement Therapy on Vasomotor Symptoms in Postmenopausal Women

21 January 2018

1 reference

Pathophysiology and treatment of menopausal hot flashes

21 January 2018

1 reference

Estrogen raises the sweating threshold in postmenopausal women with hot flashes

21 January 2018

1 reference

Hot flashes: behavioral treatments, mechanisms, and relation to sleep

21 January 2018

1 reference

Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes

21 January 2018

1 reference

Symptom experience after discontinuing use of estrogen plus progestin

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

21 January 2018

1 reference

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

Estrogen therapy and coronary-artery calcification.

21 January 2018

1 reference

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society

21 January 2018

1 reference

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

21 January 2018

1 reference

Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

21 January 2018

1 reference

Vasomotor symptom relief versus unwanted effects: role of estrogen dosage

21 January 2018

1 reference

Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial

21 January 2018

1 reference

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years

21 January 2018

1 reference

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief

21 January 2018

1 reference

Progestins and breast cancer

21 January 2018

1 reference

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

21 January 2018

1 reference

Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms

21 January 2018

1 reference

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

21 January 2018

1 reference

Breast cancer after use of estrogen plus progestin in postmenopausal women

21 January 2018

1 reference

Bioidentical hormone therapy: a review

21 January 2018

1 reference

Bioidentical hormone therapy: a panacea that lacks supportive evidence

21 January 2018

1 reference

Bioidentical hormones for menopausal therapy

21 January 2018

1 reference

Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women

21 January 2018

1 reference

Percutaneous administration of progesterone: blood levels and endometrial protection

21 January 2018

1 reference

21 January 2018

Vulvovaginal complaints

1 reference

Urogenital atrophy: prevention and treatment

21 January 2018

1 reference

The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry

21 January 2018

1 reference

Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol

21 January 2018

1 reference

Vulvovaginal atrophy: new and upcoming approaches

21 January 2018

1 reference

Treatment of urogenital atrophy with low-dose estradiol: preliminary results

21 January 2018

1 reference

Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet

21 January 2018

1 reference

Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.

21 January 2018

1 reference

Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women

21 January 2018

1 reference

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet

21 January 2018

1 reference

Endocrine and clinical effects of micronized estradiol administered vaginally or orally

21 January 2018

1 reference

Placement of the vaginal 17beta-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17beta-estradiol toward the uterus or periurethral areas, thereby modifying efficacy and endometrial safety

21 January 2018

1 reference

The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency

21 January 2018

1 reference

Endometrial thickness and uterine diameter not affected by ultralow doses of 17beta-estradiol in elderly women

21 January 2018

1 reference

Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy

21 January 2018

1 reference

Low-potency oestrogen and risk of endometrial cancer: a case-control study

21 January 2018

1 reference

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study

21 January 2018

1 reference

Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors

21 January 2018

1 reference

A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials

21 January 2018

1 reference

Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.

21 January 2018

1 reference

Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy

21 January 2018

1 reference

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

21 January 2018

1 reference

Safety assessment of raloxifene over eight years in a clinical trial setting

21 January 2018

1 reference

Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.

21 January 2018

1 reference

Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms

21 January 2018

1 reference

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety

21 January 2018

1 reference

Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial

21 January 2018

1 reference

Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis

21 January 2018

1 reference

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity

21 January 2018

1 reference

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

21 January 2018

1 reference

Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief

21 January 2018

1 reference

Venlafaxine for the control of hot flashes: results of a longitudinal continuation study

21 January 2018

1 reference

Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial

21 January 2018

1 reference

Venlafaxine Hydrochloride for the Treatment of Hot Flashes

21 January 2018

1 reference

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial

21 January 2018

1 reference

Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety

21 January 2018

1 reference

Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study

21 January 2018

1 reference

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

21 January 2018

1 reference

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

21 January 2018

1 reference

Paroxetine versus placebo for women in midlife after hormone therapy discontinuation

21 January 2018

1 reference

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study

21 January 2018

1 reference

A double blind study to evaluate the effect of methyldopa on menopausal vasomotor flushes

21 January 2018

1 reference

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society

21 January 2018

1 reference

The effects of relaxation response training on menopausal symptoms.

21 January 2018

1 reference

Mind control of menopause

21 January 2018

1 reference

Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.

21 January 2018

1 reference

A pilot study of a Hatha yoga treatment for menopausal symptoms

21 January 2018

1 reference

Treating the climacteric symptoms in Indian women with an integrated approach to yoga therapy: a randomized control study.

21 January 2018

1 reference

Habitual physical activity and menopausal symptoms: a case-control study

21 January 2018

1 reference

Factors associated with climacteric symptoms and the use of hormone replacement therapy.

21 January 2018

1 reference

Physical exercise and vasomotor symptoms in postmenopausal women.

21 January 2018

1 reference

Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women.

21 January 2018

1 reference

Hot flushes during the menopause transition: a longitudinal study in Australian-born women

21 January 2018

1 reference

Physical activity and risk of hot flashes among women in midlife

21 January 2018

1 reference

A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women

21 January 2018

1 reference

A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes

21 January 2018

1 reference

The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial

21 January 2018

1 reference

Other complementary and alternative medicine modalities: acupuncture, magnets, reflexology, and homeopathy

21 January 2018

1 reference

A pilot study of magnetic therapy for hot flashes after breast cancer

21 January 2018

1 reference

Randomised controlled trial of reflexology for menopausal symptoms.

21 January 2018

1 reference

A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors

21 January 2018

1 reference

The placebo-controlled trial as a test of complementary and alternative medicine: observations from research experience of individualised homeopathic treatment

21 January 2018

1 reference

Herbal medicines and perioperative care

21 January 2018

1 reference

Menopause: a review of botanical dietary supplements

21 January 2018

1 reference

Black cohosh (Cimicifuga racemosa): a systematic review of adverse events

21 January 2018

1 reference

Phytoestrogens for treatment of menopausal symptoms: a systematic review.

21 January 2018

1 reference

Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study

21 January 2018

1 reference

Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.

21 January 2018

1 reference

Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial

21 January 2018

1 reference

Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study.

21 January 2018

1 reference

Is black cohosh estrogenic?

21 January 2018

1 reference

Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms

21 January 2018

1 reference

Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2.

21 January 2018

1 reference

Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells

21 January 2018

1 reference

Influence of marketed herbal menopause preparations on MCF-7 cell proliferation

21 January 2018

1 reference

Commentary on black cohosh for the treatment of menopausal symptoms

21 January 2018

1 reference

Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial

21 January 2018

1 reference

Effect of oral gamolenic acid from evening primrose oil on menopausal flushing

21 January 2018

1 reference

Panax ginseng: a systematic review of adverse effects and drug interactions

21 January 2018

1 reference

Efficacy of kava extract for treating anxiety: systematic review and meta-analysis

21 January 2018

1 reference

Vitex agnus castus essential oil and menopausal balance: a research update [Complementary Therapies in Nursing and Midwifery 8 (2003) 148-154].

21 January 2018

1 reference

Estrogen bioactivity in fo-ti and other herbs used for their estrogen-like effects as determined by a recombinant cell bioassay

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.09.31

1 reference

21 June 2017

1 reference